ecorpin's Covid-19 response
INDIA Begins World's Largest Public Curfew...
covid-19 Response

ecorpin's response to the Coronavirus Disease (Covid-19)

Ecorpin is tracking the Covid-19 (coronavirus) situation daily, offering ongoing updates and guidance. With the virus now established in the INDIA, we are intensifying our organizational response. This website offers the latest updates and information on what we’re doing. This guidance may change quickly as new information becomes available.

Government of India is taking all necessary steps to ensure that we are prepared well to face the challenge and threat posed by the growing pandemic of COVID 19 – the Corona Virus. With active support of the people of India, we have been able to contain the spread of the Virus in our country. The most important factor in preventing the spread of the Virus locally is to empower the citizens with the right information and taking precautions as per the advisories being issued by Ministry of Health & Family Welfare.

Additional Resources

  • The Helpline Number for corona-virus(INDIA):+91-11-23978046
    Toll Free No: 1075
  • FAQ's on Covid-19 (coronavirus disease) (click here)
  • Advisory - Social Distancing (click here)
  • DoPT OM - Preventive measures to be taken to contain the spread of Novel Coronavirus (COVID-19) (click here)


March 21, 2020

COVID-19 or more commonly called Coronavirus Disease is a recent outbreak that started in Wuhan, China.
The outbreak of COVID-19, the illness caused by the 2019 novel coronavirus known as SARS-Cov2, continues to be a Pandemic and a global health challenge. As of March 21, 2020, Globally there are 276,462 confirmed cases of COVID-19.

notification #ecorpians

We encourage you to act responsibly and to make informed decisions within your control.
If you need medical, security, or mental health support while abroad on an Ecorpin-related trip, contact International SOS at +91-8637827042 or 112(india)

“Please take care of yourselves and of each other, as we strive to take care of you all.”